Cell transplantation is a promising treatment strategy for many neurological disorders, including stroke, which can target multiple therapeutic mechanisms in a sustained fashion. We investigated the ability of human mesenchymal stromal cells (MSCs) and MSC-derived SB623 cells to rescue neural cells via trophic support following an in vitro stroke model. Following oxygen glucose deprivation, cortical neurons or hippocampal slices were cocultured with either MSCs or SB623 cells separated by a semiporous membrane (prohibits cell-cell contact) or with MSC-or SB623 cell-conditioned medium. MSCs, SB623 cells, MSC-conditioned media, and SB623 cell-conditioned media all significantly reduced neural cell damage/death compared to untreated conditions, and the rescue effect of the conditioned media was dose dependent. We identified 11 neurotrophic factors secreted by MSCs and/or SB623 cells. This study emphasizes the importance of trophic support provided by marrow-derived cells, which likely contributes to the efficacy of cell therapy for brain injury.
INTRODUCTION
larly generated SB623-like cells led to enhanced functional recovery compared to transplantation of untransfected MSCs (10, 22) . Stroke is the leading cause of long-term disability and the third leading cause of death in the US (29), Although cell transplantation has been shown to be beneficial for the treatment of stroke and other neurologprompting the demand for more effective clinical treatments. Cell transplantation is a promising treatment ical disorders, the mechanisms of action are not well understood. Donor cells potentially help injured tissue strategy, which compared to other therapies has the advantage of targeting a variety of mechanisms in a susthrough cell replacement and/or by providing trophic support. Some studies show that MSCs can transdiffertained manner. Adult bone marrow-derived mesenchymal stromal cells (MSCs) are a particularly attractive entiate into neural cells, including neurons, astrocytes, and neural stem/progenitor cells, in specific in vitro (7, cell candidate for a number of reasons, including the relative ease with which they can be obtained and ex-31) or in vivo (14, 25) environments. Trophic support is a more likely therapeutic mechanism because the effects panded in vitro. Transplantation of these cells has been shown to improve functional recovery following experiof transplanted cells occur relatively quickly and persist even as donor cell survival decreases (26) . MSCs are mental focal ischemia in rodents [for review, see (26, 36) ]. MSCs can also be manipulated in vitro prior to known to produce a variety of trophic factors, which may be beneficial to the injured and regenerating brain transplantation into assuming specific phenotypes and properties. We have developed a novel human MSC-(3, 28) . Trophic factors in turn could promote cell survival, blood-brain barrier repair, angiogenesis, regenerderived cell known as SB623 by transiently transfecting MSCs with an expression vector encoding human Notch1 ation/plasticity (e.g., neurogenesis, neurite outgrowth, synapse formation), and remyelination. To address the intracellular domain (NICD; regulates stem cell fate) (7). SB623 cells have been shown to reduce the lesion complex pathology of the injured brain, it is likely that a combination of these roles occurs and is dependent on volume and promote functional recovery when delivered to rodent brains following experimental focal ischemia cytokines secreted by the donor cells. In this study we utilize in vitro models of cerebral ischemia to investigate (43). Furthermore, postischemic transplantation of simi-the ability of SB623 cells, as well as their parent MSCs, bryonic day 18 were obtained from BrainBits (Springfield, IL) and dissociated. Tissue pieces were placed in to rescue injured neural cells via trophic support. In addition, we identify specific cytokines secreted by these Hank's balanced salt solution (HBSS) with trypsin (0.25% + 1 mM EDTA) at 37°C for 5 min. The trypsincells, which may be beneficial.
EDTA was inactivated with serum-containing medium,
MATERIALS AND METHODS
removed, and then rinsed with HBSS. Tissue was then Cell and Tissue Culture triturated in HBSS containing DNase I (0.15 mg/ml; MP Biomedicals, Solon, OH). Cells were then centrifuged at Two potential human donor cell types were examined 210 × g for 5 min. Following resuspension, cells were in this study: mesenchymal stromal cells (MSCs) and plated on poly-d-lysine-coated plates at ϳ7,000 cells/ MSC-derived SB623 cells. The effects of these donor cm 2 and cultured in Neurobasal TM medium supplemented cells were examined in an in vitro model of ischemia with 2% B-27 and 0.5 mM GlutaMAX TM to minimize applied to either primary rat neurons or cultured rat hipglial cell contamination (referred to throughout the text pocampal brain slices. All reagents were from Inas "neuronal medium"). Neuronal medium was changed vitrogen (Carlsbad, CA) unless indicated otherwise.
50% every 3-4 days, and neurons were used for experiDonor Cells (MSCs and SB623 Cells) ments at 14 days in vitro to give them time to mature and form networks. Cultures were maintained at 37°C Bone marrow aspirates from healthy human adults in a humidified incubator containing 5% CO 2 and atmowere obtained from Lonza (Walkersville, MD), rinsed, spheric oxygen. and plated in tissue culture flasks. Culture medium for the generation and maintenance of donor cells was α-Organotypic Hippocampal Slices minimum essential medium (αMEM, Mediatech, HernAll procedures involving animals conformed to guidedon, VA) supplemented with 10% fetal bovine serum lines set forth in the NIH Guide for the Care and Use of (Hyclone, Logan, UT) and 1% penicillin/streptomycin Laboratory Animals. For an additional and more in vivo-(referred to throughout the text as "growth medium").
like model of cerebral ischemia, hippocampal brain Nonadherent cells were discarded, and the remaining slices were utilized. Hippocampal slices, which contain cells were passed two times using trypsin (0.25% + 1 multiple cell types normally found in the brain and remM EDTA). MSCs were then either frozen for later use tain neuronal connectivity ex vivo, were prepared using or plated for SB623 cell preparation. For SB623 prepastandard methods. Briefly, 9-day-old Sprague-Dawley ration, MSCs were transfected with pCI plasmid conrat pups (Charles River, Wilmington, MA) were euthantaining human Notch1 intracellular domain (NICD; Notch1 ized by CO 2 inhalation followed by rapid decapitation. truncated at the transmembrane domain) and neomycinHippocampi were dissected and cut (400 µm thick) usresistance gene using Fugene6 (Roche Diagnostics, Indiing a McIlwain tissue chopper. Tissue slices were placed anapolis, IN) according to the manufacturer's protocol.
on a 30-mm insert (1 slice/insert; Millipore, Billerica, The next day, medium was replaced with growth me-MA), the base of which was a polytetrafluoroethylene dium containing 100 µg/ml G418 and selection contin-(PTFE) membrane with a pore size of 0.4 µm. The insert ued for 7 days. Selection medium was then replaced was in a well containing 50% MEM plus Earl's salts, with growth medium. After removal of G418, cells were 25% HBSS, 25% horse serum, and supplemented with passed two additional times. SB623 cells were harvested 1% penicillin/streptomycin, 8.5 mM HEPES (Sigmausing trypsin-EDTA and cryopreserved for later use. For Aldrich, St. Louis, MO), 5.5 mM glucose (Sigma-Aldrich), experiments, frozen MSCs and SB623 cells from the and 0.5 mM GlutaMAX TM . The liquid in the well same human donor were thawed, replated, and allowed reached the bottom of the insert and kept the insert wet. to recover for approximately 1 week. Cells from a total After 1 day, the medium was slowly changed over to of 11 different human donors were used for this study, Neurobasal TM medium supplemented with 2% B-27 and typically testing one to three matched sets of donor cells 1.0 mM GlutaMAX TM (referred to throughout the text as (MSCs and SB623 cells derived from the same donor) "slice medium"). Slices were used at 4-6 days in vitro. per experiment. Both MSCs and SB623 cells were rouCultures were maintained at 35°C in a humidified incutinely characterized by flow cytometry analysis and bator containing 5% CO 2 and atmospheric oxygen. were found to be positive (>95%) for CD29, CD90, and CD105, and negative (<5%) for CD31, CD34, and CD45, Oxygen Glucose Deprivation Model indicating their mesenchymal nature.
Oxygen-glucose deprivation (OGD) is a well-characNeurons terized in vitro model of ischemia (8, 23) . This insult involves the deprivation of oxygen and nutrients for a spePrimary rat neurons were used in an in vitro model of cerebral ischemia. Rat cortical tissue pieces from emcific period of time followed by reoxygenation under normal culture conditions. Medium was changed to dedonor cells affected recovery of neurons. At 24 h post-OGD, cell damage was assessed, the medium was oxygenated Dulbecco's modified Eagle's medium without glucose [after one rinse with Dulbecco's phosphatechanged to fresh neuronal medium, and inserts containing donor cells were added. Then cell damage was asbuffered saline (DPBS)] and plates containing neurons or slices were placed in an anaerobic chamber. The sessed after another 24 h (i.e., 48 h after the initial OGD insult). chamber was housed in a 37°C humidified incubator and was made anaerobic by flushing with 95% N 2 /5% CO 2 prior to and during the experiment. The level of O 2 was Conditioned Media measured and maintained at 0.0% using a Proox sensor
We also studied the role of trophic support provided and controller (BioSpherix, Redfield, NY). Neurons or by donor cells by culturing post-OGD neural cells with slices were exposed to OGD for 60 or 90 min, respecdonor cell-conditioned medium. Donor cells were grown tively. Parallel control cultures received normal neuronal on either 12-well (for neuron studies) or six-well (for or slice medium and were placed in the same incubator slice studies) plates to 80-100% confluence (ϳ10,000 outside of the anaerobic chamber (therefore at atmocells/cm 2 ). Then, serum-containing growth medium was spheric oxygen) for the same amount of time. Immediremoved, donor cells were rinsed one time in DPBS (to ately after OGD or control conditions, the medium was remove serum), and neuronal or slice medium was changed again to neuronal or slice medium. At this time, added. Donor cell-conditioned neuronal or slice medium neurons or slices were combined with either donor cells was collected 24 h later and immediately added to wells or donor cell-conditioned medium as described below.
with neurons (medium from n = 8 matched donors) or slices (medium from n = 5 matched donors), respec-
Coculture of Donor Cells and Neural Cells
tively. The donor cell-conditioned media was added imFollowing exposure to OGD, neurons or brain slices mediately following OGD (or control non-OGD condiwere cocultured with donor cells (either MSCs or SB623 tions), and cell damage was assessed 24 h later. Untreated cells). Donor cells were separated from either neurons wells received fresh neuronal or slice medium only. or brain slices by a porous membrane (0.4 µm), which To determine whether there was a dose-dependent efallowed for the exchange of molecules, but prohibited fect, conditioned media at various dilutions were tested cell-cell contact. Cortical neurons were cultured in 12- for their ability to rescue neurons post-OGD. Donor cellwell plates for 14 days in vitro prior to OGD. Donor conditioned medium (n = 5 matched donors) was obcells (n = 11 matched donors) were plated in 12-well intained as described above and diluted in neuronal meserts (polyester, 1.12 cm 2 ; Corning, Lowell, MA) and dium at one of the following dilutions: 1:1, 1:10, 1:50, grown to 80-100% confluence (ϳ10,000 cells/cm 2 ) in or 1:100. The diluted conditioned medium was added to serum-containing growth medium. Prior to placing doneurons immediately after OGD (or control non-OGD nor cell-containing inserts into 12-well plates containing conditions) and cell damage was assessed 24 h later. neurons, the donor cells were rinsed one time with Untreated wells received fresh neuronal medium only. DPBS and medium was changed to neuronal medium, consequently removing serum from the coculture. UnAssessment of Cell Damage treated neurons received donor cell-free (neuronal medium only) inserts. Hippocampal slices were cultured on At 24 and 48 (for slices only) h post-OGD, cell damage was assessed by quantifying the concentration of inserts placed inside six-well plates, and donor cells (n = 6 matched donors) for coculture with slices were grown lactate dehydrogenase (LDH) released into the medium, which is directly proportional to cell damage/death; and in six-well plates to 80-100% confluence (ϳ10,000 cells/cm 2 ) in serum-containing growth medium. Prior to normalizing to the appropriate control conditions. Neurons or slices exposed to non-OGD control conditions adding inserts containing brain slices to six-well plates containing donor cells, the donor cells were rinsed once were also cocultured with donor cells, in conditioned medium or in neuronal/slice medium only to account for with DPBS, and medium was changed to slice medium, thus removing serum from the coculture. Untreated LDH release from uninjured cultures and from donor cells. Results are thus reported as the fold change in slices went into cell-free (slice medium only) wells. Donor cells were combined with neural cells (neurons or LDH release for neurons or slices that underwent OGD followed by treatment, compared to neurons or slices slices) immediately following OGD and were cocultured for 24 or 48 (slices only) h, at which time neural cell that underwent non-OGD control conditions followed by the same treatment. LDH was assayed using the Cytodamage was assessed.
For a subset of experiments, coculture of donor cells toxicity Detection Kit from Roche Applied Science (Indianapolis, IN) according to the manufacturer's proto-(n = 4 matched donors) with neurons was initiated at a later time to determine if delaying the addition of the col, and results were read on a SpectraMax Plus plate reader (Molecular Devises, Sunnyvale, CA). A standard factor-2 and -7 (FGF-2, -7), glial cell line-derived neurotrophic factor (GDNF), granulocyte colony stimulating curve for LDH concentration was made with serial dilutions of bovine LDH (Sigma-Aldrich). Sampling for factor (GCSF), heparin binding-epidermal growth factor like growth factor (HB-EGF), hepatocyte growth factor each experiment included two to four wells/group for neurons and five to six wells/group for slices. Data from (HGF), insulin-like growth factor-1 (IGF-1), interleukin-1α, -6, and -8 (IL-1α, -6, -8), leukocyte inhibitory facmultiple wells were then averaged to obtain the value for each human donor or for "OGD only" for a specific tor (LIF), matrix metalloproteinase-1 (MMP-1), monocyte chemoattractant protein-1 (MCP-1), nerve growth experiment. These values for each donor or each experiment (for "OGD only") were then used for statistical factor (b-NGF), neurotrophin-3 (NT-3), platelet-derived growth factor (PDGF-AA), stromal cell-derived factor analysis.
As an additional outcome measure for cell damage, (SDF-1), transforming growth factor-α and -β (TGF-α, -β), tumor necrosis factor-α (TNF-α), and vascular enpropidium iodide uptake was assessed. Propidium iodide permeates cell membranes of damaged/dying cells, dothelial growth factor (VEGF). Relative amounts of cytokine expression were compared to levels found in where it binds to DNA, resulting in greatly increased fluorescent intensity. At 24 (neurons) or 48 (slices) h the OptiMEM only control by comparing the normalized signal intensities. Per the recommendation of Raypost-OGD, media was changed to 5 µM propidium iodide (Sigma-Aldrich) in PBS, incubated at 37°C for 1.5
Biotech, if the signal intensity for a given cytokine in a given sample was over 1.5 times higher than the signal h, and rinsed twice in PBS. Microscopy (Zeiss, Oberkochen, Germany) was performed to evaluate propidium intensity for the OptiMEM only control, then that conditioned medium sample was considered to have detectiodide fluorescence. To further confirm the validity of using LDH as a quantitative measure of neural cell damable levels of that cytokine. Notably, certain growth factors are known to contain heparin-binding domains and, age, the propidium iodide uptake was also quantified for neurons cocultured with MSCs or SB623 cells (n = 4 therefore, although secreted by donor cells, may not become soluble in the medium because they instead bind matched donors) or MSC-or SB623 cell-conditioned media (n = 4 matched donors) following OGD. Cells to the endogenous heparin on the cell. To test for the production of such factors by MSCs or SB623 cells, for were counted in representative micrographs from four different wells per group using ImageJ software (NIH) two matched donors, heparin (50 µg/ml) was added to Opti-MEM daily until conditioned medium was colto determine the percentage of propidium iodide-positive cells. The percentage of propidium iodide-positive lected (a total of three days). cells for neurons that underwent OGD was then normalStatistical Analysis ized to the neurons that underwent non-OGD control For each experiment (which included two to four conditions followed by the same treatment. The results wells/group for neurons and five to six wells/group for for cell damage were indistinguishable when assessed slices), a mean value indicating the fold change in LDH by propidium iodide uptake versus LDH release. Thus, release in OGD versus the matched control condition the LDH assay was consistently used to obtain quantitawas obtained for: 1) the treatment condition for each cell tive assessments of cell damage and is reported below. type (either MSCs or SB623 cells), one value per human Assessment of Cytokines in Conditioned Medium donor tested and 2) the untreated group (one value for each round of OGD). For statistical comparison (SigmaTo identify which trophic factors are secreted by Stat, StyStat Softwarre, San Jose, CA) each of these valMSCs and SB623 cells, the protein levels of specific ues was used and comparisons were made using onecandidate trophic factors in donor cell-conditioned meway ANOVA between the following groups: 1) OGD dium were measured. To obtain conditioned medium, only (untreated condition), 2) OGD + MSCs or OGD + MSCs and SB623 cells (n = 5 matched donors) were MSC-conditioned medium, and 3) OGD + SB623 cells cultured separately in growth medium to ϳ90% confluor OGD + SB623 cell-conditioned medium. Additional ence (ϳ15,000 cells/cm 2 ). The medium was then repairwise comparisons were made using Tukey's test. An placed with Opti-MEM medium (ϳ200,000 cells/ml), alpha value of 0.05 was used to assess if the means were and the conditioned medium was collected 72 h later. A significantly different. Data are presented throughout the semiquantitative custom Quantibody array (RayBiotext as mean ± SD unless indicated otherwise. tech, Norcross, GA) was used to determine which of following 30 cytokines were detectable in the donor RESULTS cell-conditioned media: bone morphogenetic proteinsMSCs and SB623 Cells Rescue Neural Cells 4, -6, and -7 (BMP-4, -6, -7), brain-derived neurotrophic Following OGD factor (BDNF), ciliary neurotrophic factor (CNTF), Dickkopf-1 and -4 (DKK-1, -4), epidermal growth facCerebral ischemia was modeled in vitro using a wellestablished oxygen-glucose deprivation (OGD) protocol tor (EGF), erythropoietin receptor, fibroblast growth applied to either primary rat cortical neurons or hipporites were partially preserved when neurons were cocultured with donor cells (Fig. 2) . campal brain slices. Neurons or brain slices that were exposed to 60 or 90 min of OGD, respectively, had sig-
The OGD insult to hippocampal slices resulted in a slightly more severe injury than neurons with 6.6 ± 3.3 nificantly more cell death compared to uninjured controls by 24 (neurons and slices) or 48 h (slices) postand 5.3 ± 2.6 times more LDH release compared to uninjured controls at 24 and 48 h post-OGD, respectively. OGD (p < 0.05), which is consistent with previous studies using these models (19, 20) . Immediately following When slices were cocultured with MSCs or SB623 cells for 24 h, the amount of neural cell damage significantly exposure to OGD, neurons or brain slices were cocultured with marrow-derived donor cells (either MSCs or decreased (p < 0.05) to 2.7 ± 1.2 or 2.6 ± 0.9 times more LDH release than corresponding uninjured controls, re-SB623 cells), separated by a semiporous membrane (pore size 0.4 µm), which allowed for the exchange of spectively. This was further enhanced after 48 h of coculturing with MSCs or SB623 cells, resulting in only soluble molecules, but precluded cell-cell contact. There was a significant reduction in neural cell damage, 1.9 ± 0.8 or 1.8 ± 0.5 times more LDH release than corresponding uninjured controls, respectively. Moreover, measured by LDH release, when neurons/slices were cocultured with either MSCs or SB623 cells compared to qualitative analysis of propidium iodide uptake in the hippocampal slices further demonstrated that coculturing untreated conditions (p < 0.05) (Fig. 1) . Importantly, the ability of the human donor cells to rescue the neural with MSCs or SB623 cells reduces cell damage (Fig. 2) . Note that the viability of the donor cells was not affected cells was consistent across multiple human donors. For neurons, injured cultures had 4.6 ± 2.2 times more LDH by the injured environment. For example, the viability (measured by trypan blue uptake) of donor cells after 48 release compared to uninjured controls at 24 h post-OGD. However, when neurons were cocultured with h in coculture with injured and control slices was 98 ± 3% and 99 ± 2%, respectively. MSCs or SB623 cells, neuronal cell damaged significantly decreased (p < 0.05) to only 1.4 ± 0.3 or 1.2 ± 0.2 When the coculturing of neurons with MSCs or SB623 cells began at 24 h (instead of immediately) posttimes more LDH release than corresponding uninjured controls, respectively. Qualitative analysis of the neu-OGD, there was still a significant reduction in neuronal cell damage 24 h later (48 h post-OGD) compared to ronal morphology after injury revealed that the neurites were damaged by OGD at 24 h postinjury, but the neuuntreated conditions at both 24 and 48 h post-OGD (p < 0.05) (Fig. 3) .
At 24 h post-OGD, injured neurons MSC-and SB623 Cell-Conditioned Medium Rescues
Neural Tissue Following OGD had 3.0 ± 0.7 more LDH release than uninjured controls, which increased to 7.0 ± 1.8 times more LDH release than uninjured controls by 48 h post-OGD. Coculturing
Because donor cells and neural cells were not in direct contact during coculture, the above data indicate neurons with MSCs or SB623 cells for the latter 24 h significantly decreased (p < 0.05) neuronal cell damage that the donor cells likely provide beneficial cytokines and/or actively buffer the toxic environment. To further to 1.3 ± 0.5 or 0.9 ± 0.3 times more LDH release, respectively, than corresponding uninjured controls. These test the cytokine secretion hypothesis, we tested the ability of the donor cell-conditioned media to affect injured data indicate that donor cells are able to rescue injured neural cells at multiple time points of intervention. neural cells. Conditioned medium was obtained by cul- turing MSCs or SB623 cells in either neuronal or slice antibody array from RayBiotech. For this analysis, conditioned medium was obtained by culturing MSCs or medium for 24 h. Immediately following the ischemic insult, the medium in contact with neurons or brain SB623 cells in serum-free medium for 72 h (ϳ200,000 cells/ml). Relative amounts of cytokine expression in slices was changed to donor cell-conditioned medium, and cell damage was assessed 24 h later. Neurons and conditioned medium were compared to levels found in the medium only (without cells) control to account for hippocampal slices that were given either MSC-or SB623 cell-conditioned medium had significantly less cytokines present in the medium. Thus, for each donor cell type tested (either MSCs or SB623 cells), the mean cell damage compared to untreated conditions (p < 0.05) (Fig. 4) . At 24 h post-OGD, neurons and slices had 3.3 ± fold-change versus medium only is reported. Per recommendation by RayBiotech, for each cytokine, a signal 1.2 and 5.8 ± 3.6 times more LDH release, respectively, than uninjured controls. Culturing neurons with MSCwith a fold-change greater than 1.5 times the "medium only" control indicates that the cytokine was secreted by or SB623 cell-conditioned media for 24 h significantly reduced (p < 0.05) cell damage to 1.2 ± 0.2 or 1.1 ± 0.2 the donor cells. Based on this analysis, the following 10 cytokines were detected in conditioned medium from eitimes more LDH release, respectively, than corresponding uninjured controls. Culturing slices with MSC-or ther MSCs or SB623 cells: BMP-4, DKK-1, FGF-7, HB-EGF, IL-6, IL-8, MCP-1, MMP-1, PDGF-AA, and SB623 cell-conditioned media for 24 h significantly reduced (p < 0.05) cell damage to 2.8 ± 1.0 or 2.6 ± 0.4 VEGF. A subset of cytokines had increased expression when heparin was added daily to the medium during times more LDH release, respectively, than corresponding uninjured controls. There were no significant differthe conditioning period. Of these, HGF was present in sufficiently high levels to be considered to be secreted ences in cell damage between neurons or brain slices treated with donor cells in coculture compared to those by the donor cells. Thus, we found that 11 of the 30 cytokines tested were secreted by either MSCs or SB623 treated with donor cell-conditioned medium (p > 0.05 in all cases). Furthermore, the observed rescue effect on cells. While all 11 of these cytokines were detected in SB623 cell-conditioned medium, IL-8 and MMP-1 were injured neurons decreased when the conditioned medium was diluted, indicating a dose-dependent response not detected in MSC-conditioned medium. Furthermore, four of the cytokines tested were consistently found at to the conditioned medium (Fig. 5) . These data reveal that factors secreted by MSCs and SB623 cells are beneincreased levels in SB623 cell-conditioned medium compared to MSC-conditioned medium: DKK-1, IL-6, IL-8, ficial to injured neural cells, and that the concentration of such factors is important.
and MCP-1. Results are summarized in Table 1 .
DISCUSSION

MSCs and SB623 Cells Secrete Multiple Cytokines That Are Potentially Beneficial to Neural Cells
In this study we demonstrate that both MSCs and SB623 cells are able to rescue neural cells in vitro The data presented above suggest that marrowderived stromal cells are able to rescue injured neural through a trophic support mechanism. A well-characterized OGD model was used to apply an ischemic insult cells by secreting one or more trophic factors. The presence of 30 specific candidate trophic factors in donor to either primary neurons or hippocampal slices. Two types of potential human donor cells were tested for cell-conditioned medium was assessed using a custom factor(s) is critical. Previous studies have shown that MSCs produce a There was a significant increase in cell survival when primary neurons were cocultured with either MSCs or variety of neurotrophic factors, including BDNF, FGF-2, GDNF, HGF, IGF-1, MCP, NGF, NT-3, PDGF, and SB623 cells following ischemic insult. A previous study by Zhong et al. (45) showed that coculturing rat MSCs VEGF (3,13,27,40). Here we examined MSC-and SB623 cell-conditioned medium for the presence of 30 with hippocampal slices following OGD led to both increase in cell survival and increase in neurite outgrowth.
candidate cytokines, and found that the following 11 were secreted by these cells in the specific conditions Here we corroborate these results and find that human MSCs as well as their derivatives, SB623 cells, improve tested here: BMP-4, DKK-1, FGF-7, HB-EGF, HGF, IL-6, IL-8, MCP-1, MMP-1, PDGF-AA, and VEGF. neural cell survival when they are cocultured with hippocampal slices following OGD.
With the exception of DKK-1, all of these proteins are involved in mechanisms that are potentially beneficial Notably, a decrease in neural cell damage was observed when donor cells were added either immediately to neural tissue following an ischemic insult, such as promoting neural cell survival, migration, neurite outafter the OGD or 24 h later, suggesting that the donor cells can rescue injured neurons at multiple time points growth, neurogenesis, gliogenesis, and angiogenesis (see Table 2 for a summary of potential beneficial mechaof intervention. This is important for clinical applications, as it is preferable to have a wide treatment winnisms).
Further studies are warranted to determine the spedow, particularly with stroke patients whose early symptoms often go unrecognized. The coculture system used cific combination of factors that are critical for the rescue effects observed in the study presented here. Interin these studies separated the donor cells from the neurons or slices by a semiporous membrane, which preestingly, the SB623 cells, which are MSCs transiently transfected with an NICD expression vector, retain their vented direct cell-cell contact. Therefore, we infer that trophic support is playing a role. There are additional ability to rescue neural cells and secrete multiple trophic factors. Moreover, the production of certain trophic facfactors that could be contributing to the observed rescue effect, such as the presence of the donor cells actively tors by SB623 cells is higher compared to their parent MSCs. One of these, DKK-1, suppresses osteogenesis buffering toxic components present after injury. Thus, in order to further isolate the effects of trophic factors, by inhibiting Wnt signaling (9). The remaining three factors found at higher levels in medium conditioned by donor cell-conditioned medium was also tested for its ability to rescue injured neural cells. Both MSC-and SB623 cells versus MSCs were IL-6, IL-8, and MCP-1. All of these are proinflammatory molecules that have SB623 cell-conditioned medium rescued injured neurons or slices, and this occurred in a dose-dependent manner.
been shown to play a dual role after CNS injury (4,24). In addition, both IL-8 and MCP-1 enhance MSC migraThis suggests that the observed beneficial effects are tion (39). Compared to MSCs, SB623 cells may be instroke and other neurological disorders is the ability of these cells to respond to the needs of the injured tissue. creasing cytokine production as they approach a senescent state. Previous reports indicate that when fibroblasts Studies have shown that human MSCs increase trophic factor production when cultured with injured brain tissue become senescent, the production of cytokines involved in matrix remodeling and local inflammation increases extracts (5). In the study presented here, we did not detect significant differences in neural cell damage (as (33). We have seen that SB623 cells display more senescent qualities (e.g., increased expression of p16Ink4A) measured by the relative amount of LDH release) when injured neural cells were treated for 24 h with donor compared to MSCs, and that this is a result of the transient expression of the NICD, and not strictly a result of cell-conditioned medium compared to when donor cells were present. This implies that any communication bea longer culture period compared to their parent MSCs (unpublished observations).
tween neural cells and donor cells that could potentially alter the observed rescue effect was not detectable using One potential advantage of using cell therapy to treat An ELISA assay was performed to detect cytokines present in conditioned OptiMEM  medium from five matched donors. A fold-change of 1.5 or greater indicates there is a difference between the two groups compared (indicated by bold font). Out of 30 cytokines tested, 10 cytokines were detected in MSC-or SB623 cell-conditioned medium. Four cytokines were found at higher levels in medium conditioned by SB623 cells compared to MSCs for all five of the donors tested (indicated by italic font). *Notably, HGF was also detected in two out of two donors when heparin was added daily to the conditioned medium (not shown). by increasing trophic factor secretion. It could also be 
